Las Vegas, NV -- (SBWIRE) -- 01/04/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Endeavour Silver Corp(NYSE:EXK), Amyris Inc(NASDAQ:AMRS), Zogenix, Inc.(NASDAQ:ZGNX), First Majestic Silver Corp(NYSE:AG)
Endeavour Silver Corp(NYSE:EXK) was a volume gainer of 1.91 million shares and the average volume of the stock remained 1.26 million shares. The stock opened the session at $3.76 and finished at the end of the day at $3.81 and the stock escalated 4.96%.The market capitalization of the stock remained 380.01 million. Endeavour Silver Corp. (Endeavour) is engaged in the evaluation, acquisition, exploration, development and exploitation of silver mining properties in Mexico and in exploration in Chile. The Company’s producing mines include Guanacevi mine, Bolanitos Mine and El Cubo.
For How Long EXK will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Amyris Inc(NASDAQ:AMRS) exchanged 1.88 million shares and the average volume remained 445,292.00 shares. The stock closed the session at $4.71 with the drop of -10.96%. Amyris, Inc., a renewable products company, engages in the provision of various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010.
Why Should Investors Buy AMRS After the Recent Fall? Just Go Here and Find Out
Zogenix, Inc.(NASDAQ:ZGNX) decreased -0.29% and its closing price was $3.43. The volume of the stock was 1.87 million shares and the average volume remained 1.96 million shares. The market capitalization of the stock remained 474.83 million. The beta of the stock remained 2.54. Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Its commercial product includes Sumavel DosePro (sumatriptan injection), a delivery system that offers needle-free subcutaneous administration of sumatriptan for the acute treatment of migraine and cluster headache.
Will ZGNX Get Buyers Even After The Recent Rally? Find Out Here
First Majestic Silver Corp(NYSE:AG) exchanged 1.84 million shares in the previous trading session, and its average trading remained 1.07 million shares. AG advanced 6.63% and it closed the trading at $10.45. The market capitalization of the stock remained 1.15 billion. First Majestic Silver Corp. engages in the acquisition, development, and exploration of mineral properties with a focus on silver projects in México. The company was formerly known as First Majestic Resource Corp. and changed its name to First Majestic Silver Corp. in November 2006.
For How Long AG’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)